Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-14 OYLER JOHN Chief Executive Officer Sale −4,759 $367.52 $1.7M 12,189
2021-09-14 OYLER JOHN Chief Executive Officer Sale −10,989 $368.51 $4.0M 1,200
2021-09-14 OYLER JOHN Chief Executive Officer Sale −1,100 $369.65 $407K 100
2021-09-14 OYLER JOHN Chief Executive Officer Sale −100 $370.48 $37K 0
2021-09-13 Huang Jane CMO, Hematology Sale −4,219 $355.37 $1.5M 8,682
2021-09-13 Huang Jane CMO, Hematology Sale −1,400 $356.46 $499K 7,282
2021-09-13 Huang Jane CMO, Hematology Sale −1,300 $357.54 $465K 5,982
2021-09-13 Huang Jane CMO, Hematology Sale −1,700 $359.15 $611K 4,282
2021-09-13 Huang Jane CMO, Hematology Sale −1,800 $359.88 $648K 2,482
2021-09-13 Huang Jane CMO, Hematology Sale −900 $361.05 $325K 1,582
2021-09-13 Huang Jane CMO, Hematology Sale −1,581 $362.80 $574K 1
2021-09-13 Huang Jane CMO, Hematology Sale −1 $363.45 $363 0
2021-09-10 AMGEN INC 10% owner Purchase +165,529 $302.06 $50.0M 18,943,802
2021-09-02 OYLER JOHN Chief Executive Officer Sale −4,400 $324.50 $1.4M 20,099
2021-09-02 OYLER JOHN Chief Executive Officer Sale −2,828 $325.56 $921K 17,271
2021-09-02 OYLER JOHN Chief Executive Officer Sale −3,810 $326.43 $1.2M 13,461
2021-09-02 OYLER JOHN Chief Executive Officer Sale −2,176 $327.28 $712K 11,285
2021-09-02 OYLER JOHN Chief Executive Officer Sale −800 $328.70 $263K 10,485
2021-09-02 OYLER JOHN Chief Executive Officer Sale −2,500 $329.79 $824K 7,985
2021-09-02 OYLER JOHN Chief Executive Officer Sale −2,100 $330.82 $695K 5,885

Page 59 of 71 · 1,406 trades